Investors in the pharmaceutical company Elan are suing Steven Cohen's SAC Capital Advisors, alleging that it engaged in illegal insider trading in Elan's options before clinical trial results were released.
Investors in the pharmaceutical company Elan are suing Steven Cohen's SAC Capital Advisors, alleging that it engaged in illegal insider trading in Elan's options before clinical trial results were released.